Passive hemagglutination assays for the detection of antibodies to herpes viruses.
A simple and effective method for the detection of antibodies to herpes simplex virus (HSV), human cytomegalovirus (HCMV) and varicella-zoster virus (VZV), has been established using the passive hemagglutination assay (PHA) in combination with viral specific glycoproteins. The results obtained with the PHA were compared with those from neutralization (NT) and complement fixation (CF) tests. The PHA test for each of the herpes viruses appears to compare favorably with the other assays tested. The specificity and sensitivity of HSV PHA to NT were 100%, whereas the specificity and sensitivity of HSV CF test to NT were 98% and 100%, respectively. For HCMV, the specificity and sensitivity of PHA to NT and PHA to CF were 100%. Similarly, the specificity and sensitivity of VZV PHA to NT were 100%. Because of the low sensitivity of the VZV CF, the sensitivity of CF to NT was 83%. Furthermore, the range of antibody titers and their absolute levels obtained in the PHAs were significantly greater than those in the NT and CF tests.
Kino
Y
Y
Chemo-Sero-Therapeutic Research Institute, Kumamoto, Japan.
Minamishima
Y
Y
D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis*; D002675:Child, Preschool; D003168:Complement Fixation Tests; D003587:Cytomegalovirus / Q000276:immunology; D006386:Hemagglutination Tests; D014645:Herpesvirus 3, Human / Q000276:immunology; D006801:Humans; D008168:Lung / Q000382:microbiology; D009500:Neutralization Tests; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D018139:Simplexvirus / Q000276:immunology*; D014759:Viral Envelope Proteins / Q000276:immunology / Q000302:isolation & purification
D000914:Antibodies, Viral; D014759:Viral Envelope Proteins